I was thinking about RCH-01 the other day and reached the opposite conclusion.
The data Shieseido have already published amounts to nothing less than a paradigm shift in how hair loss is approached and perceived. As I recall, all of the test subjects were at least at baseline levels two years after the injection. That amounts to what is essentially a vaccine for hair loss. In the same way children are immunised in advance against mumps, measles and rubella, men and women will be able to vaccinate themselves against alopecia at the earliest and most minor signs of loss. At such a modest price (I’ve seen approximations around the $1000 mark), this will shrink the hair transplant industry within about twenty years, when all existing bald men will have either had the transplant or accepted their shorn domes. Only a handful of FUE auteurs will remain; hair transplantation will be looked back on in the future as a medical curio and an almost barbarous practice for variable results.
Shiseido is tremendously underhyped considering the implications of its trial results thus far.
